To include your compound in the COVID-19 Resource Center, submit it here.

ODAC backs Afinitor, Sutent sNDAs

FDA's Oncologic Drugs Advisory Committee voted in favor of sNDAs for two drugs to

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE